Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415

Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/23897

Type:	conferenceObject
Title:	Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415
Author(s):	MALUF, FERNANDO C. SOARES, ANDREY BASTOS, DIOGO ASSED SCHUTZ, FÁBIO CRONEMBERGER, EDUARDO HENRIQUE Murilo Luz Suelen P. S. Martins David Queiroz Borges Flavio Mavignier Carcano SMALETZ, OREN Fábio A Peixoto Andrea J Gomes Felipe Melo Cruz Fabio Franke HERCHENHORN, DANIEL Rosemarie Gidekel Taiane Francieli Rebelatto Rafaela Gomes Vinicius Carrera Souza André Poisl Fay
In:	Journal o Clinical Oncology, 2022, Estados Unidos.
Issue Date:	2022
URI:	https://hdl.handle.net/10923/23897
Appears in Collections:	Apresentação em Evento

Files in This Item:

File	Description	Size	Format
Survival_analysis_of_the_randomized_phase_II_trial_to_investigate_androgen_signaling_inhibitors_with_or_without_androgen.pdf		79,67 kB	Adobe PDF	Open View